Expertise in
15
conditions

Dr. Natalie A. Afshari

Ophthalmology
Regents Of The University Of UC
9415 Campus Point Dr, 
La Jolla, CA 
Expertise in
15
conditions
Regents Of The University Of UC
9415 Campus Point Dr, 
La Jolla, CA 

Overview

Natalie Afshari is an Ophthalmologist practicing medicine in La Jolla, California.

Dr. Afshari is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Cataract, Cataract Removal, and Corneal Transplant.

She is actively involved in clinical research, co-authoring 131 peer reviewed articles and participating in 3 clinical trials.

Specialties

Ophthalmology

Licenses

Ophthalmology in CA

Hospital Affiliations

Uc San Diego Health Hillcrest - Hillcrest Med Ctr

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Regents of the University of UC
9415 Campus Point Dr, La Jolla, CA 92093

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1/2 Study to Determine Safety and Efficacy of Transplantation With Autologous Human CD34+ Hematopoietic Stem Cells (HSC) From Mobilized Peripheral Blood Stem Cells (PBSC) of Patients With Cystinosis Modified by Ex Vivo Transduction Using pCCL-CTNS or pCDY.EFS.CTNS.T260I Lentiviral Vector and Will Include Transduction Enhancer When Required During Manufacturing
A Phase 1/2 Study to Determine Safety and Efficacy of Transplantation With Autologous Human CD34+ Hematopoietic Stem Cells (HSC) From Mobilized Peripheral Blood Stem Cells (PBSC) of Patients With Cystinosis Modified by Ex Vivo Transduction Using pCCL-CTNS or pCDY.EFS.CTNS.T260I Lentiviral Vector and Will Include Transduction Enhancer When Required During Manufacturing
Enrollment Status: Completed
Publish Date: August 06, 2026
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Device
Study Phase: Phase 1/Phase 2
An 8-week Phase II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 24 or 32 Week Follow-up to Evaluate the Efficacy of rhNGF 20 µg/ml vs Vehicle in Patients With Stage 2 and 3 Neurotrophic Keratitis
An 8-week Phase II, Multicenter, Randomized, Double-masked, Vehicle Controlled Parallel Group Study With a 24 or 32 Week Follow-up to Evaluate the Efficacy of rhNGF 20 µg/ml vs Vehicle in Patients With Stage 2 and 3 Neurotrophic Keratitis
Enrollment Status: Completed
Publish Date: December 08, 2022
Intervention Type: Other, Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

131 Total Publications

A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10.
A Cross-Species Hydroquinone Model Replicates Smoking-Related Corneal Endothelial Oxidative Injury and Enables Therapeutic Screening of FGF10.
Journal: Investigative ophthalmology & visual science
Published: March 06, 2026
Similar Doctors
Expertise in
12
conditions
Dr. Robert N. Weinreb
Ophthalmology
Expertise in
12
conditions
Dr. Robert N. Weinreb
Ophthalmology
Referral may be required

Regents Of The University Of UC

9415 Campus Point Dr, 
La Jolla, CA 
 (0.1 miles away)
858-534-6290
Languages Spoken:
English
See accepted insurances

Robert Weinreb is an Ophthalmologist practicing medicine in La Jolla, California. Dr. Weinreb is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Expertise in
11
conditions
Expertise in
11
conditions
Referral may be required

Regents Of The University Of UC

9415 Campus Point Dr, 
La Jolla, CA 
 (0.1 miles away)
858-534-6290
Languages Spoken:
English
See accepted insurances

William Freeman is an Ophthalmologist practicing medicine in La Jolla, California. Dr. Freeman is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Diabetic Macular Edema (DME), and Vitrectomy.

Expertise in
15
conditions
Dr. Don O. Kikkawa
Ophthalmology
Expertise in
15
conditions
Dr. Don O. Kikkawa
Ophthalmology
Referral may be required

Regents Of The University Of UC

9415 Campus Point Dr, 
La Jolla, CA 
 (0.1 miles away)
858-534-6290
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Don Kikkawa is an Ophthalmologist practicing medicine in La Jolla, California. Dr. Kikkawa is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Eyelid Drooping, Ptosis, Graves Disease, and Thyroid Eye Disease.

Frequently Asked Questions about Dr. Natalie A. Afshari

How do I make an appointment with Dr. Natalie A. Afshari?

You can book an appointment with Dr. Natalie A. Afshari by calling their office at 858-534-6290. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Natalie A. Afshari a top-rated expert for Macular Corneal Dystrophy Type 1?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Natalie A. Afshari is classified as an Elite expert for Macular Corneal Dystrophy Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Natalie A. Afshari specialize in?

While Dr. Natalie A. Afshari is a Ophthalmology, they have specific expertise in Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, and Cataract. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.

Does Dr. Natalie A. Afshari participate in research or clinical trials?

Yes. Dr. Natalie A. Afshari has published 131 articles and abstracts on conditions like Macular Corneal Dystrophy Type 1. You can view a list of Dr. Natalie A. Afshari's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Natalie A. Afshari accept my insurance?

Dr. Natalie A. Afshari accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 858-534-6290 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Afshari's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile